Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01302-7Source: DataRank Database

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation is a research paper published in Journal of Hematology & Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 39 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access39 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 4.65)OA: goldTopics (42)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Leylah Azali,Lindsay Rosen ORCID,Qiuhong Zhao ORCID,Tracy Wiczer,Marilly Palettas ORCID

Live enrichment

PubMed:35836241 PMC:PMC9281099 OpenAlex:https://openalex.org/W4285386223

Leukemia and Lymphoma Society

Grant: CDP 2331-20

National Institutes of Health

Grant: R01-CA197870

National Institutes of Health

Grant: K23-CA178183

National Institutes of Health

Grant: K12-CA133250

Robert Wood Johnson Foundation

Grant: American Heart Association Program Grant

NCI NIH HHS

Grant: P30 CA016058

NCI NIH HHS

Grant: R01 CA197870

NHLBI NIH HHS

Grant: K23 HL155890

NCI NIH HHS

Grant: K23 CA178183

NHLBI NIH HHS

Grant: L30 HL149063

NCI NIH HHS

Grant: K12 CA133250

National Institutes of Health

Grant: 2K12CA133250-16

OSU K12 Training Grant in Oncology

National Institutes of Health

Grant: 5K23HL155890-02

Early Detection and Mechanisms of Cancer Immunotherapy Associated Cardiotoxicity

National Institutes of Health

Grant: 4K23CA178183-04

Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia

National Institutes of Health

Grant: 5R01CA197870-03

Improving BTK Directed Therapy for CLL

National Institutes of Health

Grant: 5R35CA197734-06

Targeted Therapy for Leukemia

FWCI

4.65

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-022-01302-7

publisherhttps://jhoonline.biomedcentral.com/counter/pdf/10.1186/s13045-022-01302-7

publisherhttps://link.springer.com/content/pdf/10.1186/s13045-022-01302-7.pdf

publisherhttps://link.springer.com/article/10.1186/s13045-022-01302-7/fulltext.html

journalhttps://doi.org/10.1186/s13045-022-01302-7

Fields of Study

Chronic Lymphocytic Leukemia ResearchPhagocytosis and Immune RegulationLymphoma Diagnosis and Treatment03 medical and health sciences0302 clinical medicineAntihypertensive AgentsBlood PressureHumansHypertensionMyocardial InfarctionStroke

MeSH Terms

Antihypertensive AgentsBlood PressureHumansHypertensionMyocardial InfarctionStroke

Keywords

MedicineMaceInternal medicineCardiologyMyocardial infarctionFramingham Risk ScoreHeart failureBlood pressureFramingham Heart StudyStroke (engine)IbrutinibDiseaseHypertensionCardiovascular eventsCardio-oncologyCancer-targeted TherapyAcalabrutinibResearchNeoplasms. Tumors. Oncology. Including cancer and carcinogensStrokeHumansDiseases of the blood and blood-forming organsRC633-647.5RC254-282Antihypertensive Agents

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

10.6084/m9.figshare.20317909.v1figshare

Additional file 1 of Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

10.6084/m9.figshare.20317909figshare

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

10.6084/m9.figshare.c.6096943figshare

Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation

10.6084/m9.figshare.c.6096943.v1figshare